Status:
COMPLETED
Effect of Upper-body Rowing on Cardiometabolic Risk in Spinal Cord Injured Wheelchair Users
Lead Sponsor:
Aalborg University
Collaborating Sponsors:
Aage og Johanne Louis-Hansens Fond
Conditions:
Spinal Cord Injuries
Exercise Training
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This randomized controlled trial will determine the effects of 12-weeks of wheelchair user-modified upper-body rowing on both traditional cardiometabolic risk factors in SCI manual wheelchair users.
Detailed Description
This randomized controlled trial aims to determine the effects of 12-weeks of wheelchair user-modified upper-body rowing on both traditional (insulin resistance, obesity, dyslipidemia (including low H...
Eligibility Criteria
Inclusion
- 18-65 years;
- chronic SCI (≥1 year since injury)
- individuals with sufficient sparing of arm function to participate in upper-body rowing (i.e. as a minimum excluding individuals with complete SCI at or above C5)
- using a manual wheelchair as a primary tool for mobility.
Exclusion
- Individuals who regularly engage in \>150 min/week of moderate-to-vigorous intensity physical activity
- have received a cortisone injection in the shoulder within the last four months
- have had shoulder injury within the previous year
- known medical issues (urinary tract infections, cardiovascular contraindications for exercise testing, and pressure sores)
- diagnosed diabetes or any endocrine, heart, kidney, liver disease or any other disease that may limit the ability to perform exercise.
Key Trial Info
Start Date :
January 11 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 25 2021
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT04390087
Start Date
January 11 2021
End Date
November 25 2021
Last Update
May 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aalborg University
Aalborg, Denmark, 9220